BioAgilytix Is Re-approved and Registered For The French Research Tax Credit (CIR) 

Hamburg, Germany — April 20, 2026 — BioAgilytix, a global leader in bioanalytical services, is pleased to announce that its European headquarters in Hamburg, Germany, has been re-approved and registered under France’s Crédit d’Impôt Recherche (CIR) program since 2020 with certification maintained through 2030. The Research Tax Credit (CIR) is a tax incentive designed to encourage companies’ research and development efforts by allowing the R&D-related expenses to be exempt from corporate taxes. 

In its commitment to fostering and providing a financially advantageous environment for industry growth, France offers one of the most competitive tax incentive programs for companies and startups engaged in research and development. 

Our European headquarters, registered as BioAgilytix Europe GmbH, has been granted this research tax credit based on its ongoing research and technological development expenditures. Although our laboratory is located in Germany, it is important to note that our CIR certification enables us to support clients across all companies registered in France.

With this CIR approval, French companies that work with BioAgilytix Europe can benefit from a tax credit of 30% on eligible R&D expenses (up to 100 million Euro), and 5% beyond this threshold, subject to applicable limits applying on qualifying subcontractor expenses. This represents a significant advantage for our French clients. 

French businesses investing in research may receive a tax credit that can be offset against the corporate tax liabilities. This further strengthens BioAgilytix Europe’s position as an attractive partner for French sponsors seeking a global CRO with extensive capabilities and experience.

About BioAgilytix 

BioAgilytix is the trusted partner for bioanalytical services throughout every phase of the drug development process. As a leading global bioanalytical laboratory, the company provides established and emerging pharmaceutical and biotechnology organizations with pharmacokinetic (PK), immunogenicity, biomarker, and CMC analytical testing services in a GxP environment. BioAgilytix maintains state-of-the-art laboratories in Durham, North Carolina; Boston, Massachusetts; San Diego, California; Melbourne and Brisbane, Australia; and Hamburg, Germany. For more information, please visit www.bioagilytix.com.